Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 : Market Research Report

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published: Sep. 30, 2008 - 155 Pages

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?; 2.2 Definitions
3 Healthcare Sector Review: 3.1 Healthcare Sector; 3.2 Healthcare Expenditure; 3.3 Healthcare Infrastructure; 3.4 Healthcare Policy
4 Drug Delivery Devices in Germany: 4.1 Drug Delivery Devices Overall Revenues (2000-2012); 4.2 Drug Delivery Devices Overall Volume (2000-2012); 4.3 Drug Delivery Devices Company Shares (2005-2006)
5 Inhalation Systems in Germany: 5.1 Inhalation Systems Overall Revenues (2000-2012); 5.2 Inhalation Systems Overall Volume (2000-2012); 5.3 Inhalation Systems Average Price (2000-2012); 5.4 Inhalation Systems Distribution Share (2005-2006); 5.5 Inhalation Systems Company Share (2005-2006)
6 Infusion Systems in Germany: 6.1 Infusion Systems Overall Revenues (2000-2012); 6.2 Infusion Systems Overall Volume (2000-2012); 6.3 Infusion Systems Average Price (2000-2012); 6.4 Infusion Systems Distribution Share (2005-2006); 6.5 Infusion Systems Company Share (2005-2006)
7 Needle Free Injections in Germany: 7.1 Needle Free Injections Overall Revenue (2000-2012); 7.2 Needle Free Injections Overall Volume (2000-2012); 7.3 Needle Free Injections Average Price (2000-2012); 7.4 Needle Free Injections Distribution Share (2005-2006); 7.5 Needle Free Injections Company Share (2005-2006)
8 AstraZeneca PLC Company Profile: 8.1 Company Overview; 8.2 Business Overview; 8.3 Locations And Subsidiaries; 8.4 Other Locations & Subsidiaries
9 3M Company Profile: 9.1 Company Overview; 9.2 Business Overview; 9.3 Value Chain Analysis; 9.4 SWOT Analysis; 9.5 Financial and Operational Review; 9.6 Locations And Subsidiaries
10 GlaxoSmithKline plc Company Profile: 10.1 Company Overview; 10.2 Business Overview; 10.3 Locations And Subsidiaries; 10.4 Other Locations & Subsidiaries
11 Baxter International Company Profile: 11.1 Company Overview; 11.2 Business Overview; 11.3 Value Chain Analysis; 11.4 SWOT Analysis; 11.5 Financial and Operational Review; 11.6 Locations And Subsidiaries; 11.7 Other Locations & Subsidiaries; 11.8 Baxter International Inc. Pipeline Products
12 Novartis AG Company Profile: 12.1 Company Overview; 12.2 Business Overview; 12.3 Locations And Subsidiaries; 12.4 Other Locations & Subsidiaries
13 Regulation System: 13.1 Regulation System; 13.2 Medical Equipment Approval Process; 13.3 Conformity Assessment Process; 13.4 Post Market Surveillance
14 Pricing and Reimbursement: 14.1 SHI
15 Distribution Structure
16 Appendix: 16.1 Global Markets Direct Research Methodology; 16.2 Coverage; 16.3 Secondary Research; 16.4 Primary Research; 16.5 Models; 16.6 Forecasts; 16.7 Expert Panels; 16.8 Currency Conversion; 16.9 Contact Us; 16.10 Disclaimer
1.1 List of Tables: Table 1: Healthcare Personnel by Region in Germany, 2004; Table 2: Doctors by Specialty in Germany, 2000-2004; Table 3: Hospitals by Region in Germany, 2004; Table 4: Hospital Beds by Region in Germany, 2004; Table 5: Rehabilitation Centers by Region in Germany, 2004; Table 6: Rehabilitation Center Beds by Region in Germany, 2004; Table 7: Discharges by Diagnosis in Germany, 2004; Table 8: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012; Table 9: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 10: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 11: Drug Delivery Devices, Germany, Category Revenues ($ mn), 2000-2012; Table 12: Drug Delivery Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007; Table 13: Drug Delivery Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012; Table 14: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012; Table 15: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007; Table 16: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012; Table 17: Drug Delivery Devices, Germany, Company Share by Revenue ($ mn), 2005-2006; Table 18: Inhalation Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 19: Inhalation Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 20: Inhalation Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007; Table 21: Inhalation Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 22: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 23: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 24: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 25: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 26: Inhalation Systems, Germany, Overall Volume (Units), Historic, 2000-2007; Table 27: Inhalation Systems, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 28: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007; Table 29: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 30: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007; Table 31: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 32: Metered Dose Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007; Table 33: Metered Dose Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012; Table 34: Dry Powder Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007; Table 35: Dry Powder Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012; Table 36: Inhalation Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006; Table 37: Inhalation Systems, Germany, Company Share by Revenue ($ mn), 2005-2006; Table 38: Infusion Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 39: Infusion Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 40: Infusion Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007; Table 41: Infusion Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 42: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 43: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 44: Syringe Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 45: Syringe Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 46: Infusion Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 47: Infusion Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 48: Infusion Systems, Germany, Overall Volume (Units), Historic, 2000-2007; Table 49: Infusion Systems, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 50: Infusion Disposable Sets, Germany, Overall Volume (Units), Historic, 2000-2007; Table 51: Infusion Disposable Sets, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 52: Syringe Pumps, Germany, Overall Volume (Units), Historic, 2000-2007; Table 53: Syringe Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 54: Infusion Pumps, Germany, Overall Volume (Units), Historic, 2000-2007; Table 55: Infusion Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 56: Infusion Pumps, Germany, Average Price ($), Historic, 2000-2007; Table 57: Infusion Pumps, Germany, Average Price ($), Forecast, 2007-2012; Table 58: Syringe Pumps, Germany, Average Price ($), Historic, 2000-2007; Table 59: Syringe Pumps, Germany, Average Price ($), Forecast, 2007-2012; Table 60: Infusion Disposable Sets, Germany, Average Price ($), Historic, 2000-2007; Table 61: Infusion Disposable Sets, Germany, Average Price ($), Forecast, 2007-2012; Table 62: Infusion Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006; Table 63: Infusion Systems, Germany, Company Share by Revenue ($ mn), 2005-2006; Table 64: Needle Free Injections, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Table 65: Needle Free Injections, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Table 66: Needle Free Injections, Germany, Overall Volume (Units), Historic, 2000-2007; Table 67: Needle Free Injections, Germany, Overall Volume (Units), Forecast, 2007-2012; Table 68: Needle Free Injections, Germany, Average Price ($), Historic, 2000-2007; Table 69: Needle Free Injections, Germany, Average Price ($), Forecast, 2007-2012; Table 70: Needle Free Injections, Germany, Distribution Share by Revenue ($ mn), 2005-2006; Table 71: Needle Free Injections, Germany, Company Share by Revenue ($ mn), 2005-2006; Table 72: AstraZeneca PLC, Subsidiaries; Table 73: 3M Company, SWOT Analysis, 2006; Table 74: 3M Company, Financial Statements, USD Million, 2002-2006; Table 75: 3M Company, Financial and Operational Overview, USD Million, 2002-2006; Table 76: 3M Company, Subsidiaries; Table 77: GlaxoSmithKline plc, Subsidiaries; Table 78: Baxter International Inc., SWOT Analysis, 2006; Table 79: Baxter International Inc., Financial Statements, USD Million, 2002-2006; Table 80: Baxter International Inc., Financial Ratios, USD Million, 2002-2006; Table 81: Baxter International Inc., Other Locations; Table 82: Baxter International Inc., Subsidiaries; Table 83: Novartis Medical Nutrition, Other Locations; Table 84: Currency Conversion from USD to Local Currency at 2007 Constant Rate 1
1.2 List of Figures: Figure 1: Healthcare Structure in Germany, 2000 - 2006; Figure 2: Healthcare Expenditure Sources in Germany, 2003; Figure 3: Healthcare Financing Framework in Germany, 2007; Figure 4: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012; Figure 5: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 6: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 7: Drug Delivery Devices, Germany, Category Revenues ($ mn), 2000-2012; Figure 8: Drug Delivery Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007; Figure 9: Drug Delivery Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012; Figure 10: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012; Figure 11: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007; Figure 12: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012; Figure 13: Drug Delivery Devices, Germany, Company Share (%), 2006; Figure 14: Inhalation Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 15: Inhalation Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 16: Inhalation Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 17: Inhalation Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 18: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 19: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 20: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 21: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 22: Inhalation Systems, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 23: Inhalation Systems, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 24: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 25: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 26: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 27: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 28: Metered Dose Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007; Figure 29: Metered Dose Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012; Figure 30: Dry Powder Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007; Figure 31: Dry Powder Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012; Figure 32: Inhalation Systems, Germany, Distribution Share (%), 2006; Figure 33: Inhalation Systems, Germany, Company Share (%), 2006; Figure 34: Infusion Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 35: Infusion Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 36: Infusion Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 37: Infusion Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 38: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 39: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 40: Syringe Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 41: Syringe Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 42: Infusion Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 43: Infusion Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 44: Infusion Disposable Sets, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 45: Infusion Disposable Sets, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 46: Syringe Pumps, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 47: Syringe Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 48: Infusion Pumps, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 49: Infusion Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 50: Infusion Pumps, Germany, Average Price ($), Historic, 2000-2007; Figure 51: Infusion Pumps, Germany, Average Price ($), Forecast, 2007-2012; Figure 52: Syringe Pumps, Germany, Average Price ($), Historic, 2000-2007; Figure 53: Syringe Pumps, Germany, Average Price ($), Forecast, 2007-2012; Figure 54: Infusion Disposable Sets, Germany, Average Price ($), Historic, 2000-2007; Figure 55: Infusion Disposable Sets, Germany, Average Price ($), Forecast, 2007-2012; Figure 56: Infusion Systems, Germany, Distribution Share (%), 2006; Figure 57: Infusion Systems, Germany, Company Share (%), 2006; Figure 58: Needle Free Injections, Germany, Overall Revenues ($ mn), Historic, 2000-2007; Figure 59: Needle Free Injections, Germany, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 60: Needle Free Injections, Germany, Overall Volume (Units), Historic, 2000-2007; Figure 61: Needle Free Injections, Germany, Overall Volume (Units), Forecast, 2007-2012; Figure 62: Needle Free Injections, Germany, Average Price ($), Historic, 2000-2007; Figure 63: Needle Free Injections, Germany, Average Price ($), Forecast, 2007-2012; Figure 64: Needle Free Injections, Germany, Distribution Share (%), 2006; Figure 65: 3M Company, Value Chain Analysis; Figure 66: Baxter International Inc., Value Chain Analysis; Figure 67: Flowchart for Classification of Non-invasive Devices in Germany, 2007; Figure 68: Flowchart for Classification of Invasive Devices in Germany, 2007; Figure 69: Flowchart for Classification of Invasive Devices in Germany, 2007; Figure 70: Classification of Invasive Devices in Germany, 2007; Figure 71: Classification of Invasive Devices in Germany, 2007; Figure 72: Flowchart for Classification of Active Devices in Germany, 2007; Figure 73: Flowchart for Classification of Active Devices in Germany, 2007; Figure 74: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007; Figure 75: Conformity Assessment of Class-I Medical Devices in Germany, 2007; Figure 76: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007; Figure 77: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007; Figure 78: Conformity Assessment of Class-III Medical Devices in Germany, 2007; Figure 79: Global Markets Direct Methodology

Abstract

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Germany drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Germany

Scope

The report provides drug delivery devices information broken down into detailed categories and segments in Germany.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Germany.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Table of Contents

Abstract